DexCom Announces Upcoming Conference Presentation
November 27 2017 - 8:00AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on DexCom at the following upcoming investor
conference:
- Quentin Blackford, Executive Vice
President, Chief Financial Officer; and Matthew Dolan, Vice
President Corporate Development will present an update on the
company at the BMO Prescriptions for Success Healthcare Conference
in New York City, New York on Thursday, December 14, 2017 at
11:00am (EST). The presentation, which will occur live at The
Westin Grand Central Hotel, will be concurrently webcast.
The link to the webcasts will be available on the DexCom website
at www.dexcom.com by navigating to “Our Company,” then “Investor
Relations,” and finally “Events and Webcasts” and will be archived
there for future reference.
About DexCom, Inc.DexCom, Inc., headquartered in San
Diego, California, is developing and marketing continuous glucose
monitoring systems for ambulatory use by patients and by healthcare
providers in the hospital.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171127005366/en/
DexCom, Inc.Steven R. PacelliExecutive Vice President,
Strategy and Corporate Development(858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Aug 2024 to Sep 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Sep 2023 to Sep 2024